Argent Biopharma Limited has released a press release.
Binding Term Sheet for distribution of CannEpil in Israel
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- 3,250 Prescriptions Milestone Surpassed
- Ethics Committee Approval for CannEpil Phase IIb Trial
- Binding Term Sheet Signed for Distribution of ArtemiC
- Voluntary Suspension
- Phase II Clinical Trial on COVID-19 Patients Commenced
Later from Argent Biopharma
- Sale of MGC Nutra to US CBD and Hemp Wellness Company
- MXC Awarded 3-year EU GMP Manufacturing Licence
- COVID-19 Clinical Trial Site Expansion into India
- MGC Pharma awarded Import Licence by Office of Drug Control
- MXC Cannabis Research Permit Granted for RMIT Programs
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma